Elite Pharmaceuticals, Inc.
ELTP
$0.26
$0.00-1.08%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 79.14% | 163.34% | 154.37% | 178.57% | 158.56% |
| Total Receivables | 39.27% | 104.46% | 162.98% | 90.60% | 76.79% |
| Inventory | 25.02% | 30.91% | 24.51% | 28.24% | 39.95% |
| Prepaid Expenses | 65.29% | 36.54% | 80.51% | 6.98% | 25.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 47.04% | 94.16% | 101.44% | 89.42% | 80.40% |
|
|
|||||
| Total Current Assets | 47.04% | 94.16% | 101.44% | 89.42% | 80.40% |
| Net Property, Plant & Equipment | -3.53% | -7.75% | -5.52% | -6.13% | -6.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -100.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.81% | -45.68% | -43.14% | -37.32% | -34.59% |
| Total Assets | 25.44% | 43.47% | 39.29% | 32.94% | 26.74% |
|
|
|||||
| Total Accounts Payable | 9.87% | 104.67% | 11.67% | 72.67% | 95.20% |
| Total Accrued Expenses | 40.29% | 177.89% | 47.69% | 11.38% | -30.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.46% | 5.70% | -0.29% | -5.04% | -6.55% |
| Total Finance Division Other Current Liabilities | 2,323.00% | 71.63% | 55.85% | -38.05% | 6.06% |
| Total Other Current Liabilities | 2,323.00% | 71.63% | 55.85% | -38.05% | 6.06% |
| Total Current Liabilities | 182.84% | 46.88% | -10.22% | -16.96% | -23.20% |
|
|
|||||
| Total Current Liabilities | 182.84% | 46.88% | -10.22% | -16.96% | -23.20% |
| Long-Term Debt | -7.62% | -7.54% | -7.45% | -7.52% | -7.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -37.11% | -33.30% | -29.62% | -25.59% | -20.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -31.17% | -16.66% | 82.22% | 420.84% |
| Total Liabilities | -45.26% | -8.08% | -15.12% | 35.99% | 115.09% |
|
|
|||||
| Common Stock & APIC | 0.27% | 0.28% | 0.26% | 0.23% | 0.14% |
| Retained Earnings | 44.77% | 37.18% | 31.52% | 10.98% | -9.34% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 119.84% | 84.78% | 120.37% | 30.29% | -18.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 119.84% | 84.78% | 120.37% | 30.29% | -18.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 119.84% | 84.78% | 120.37% | 30.29% | -18.14% |
|
|
|||||